LENZ Therapeutics, Inc.
LENZ- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001815776
No open-market purchases or sales by LENZ Therapeutics, Inc. insiders were filed in the last 90 days; 145 institutions reported holding it in 13F filings for Q2 2026, worth $197.3M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in LENZ Therapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 51
- +51 vs. Q1 2021
- Shares held
- 32.2M
- +32.2M vs. Q1 2021
- Total value
- $981.4M
- +$981.4M vs. Q1 2021
- New holders
- 51
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LENZ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 145 | $197.3M |
| Q1 2026 | 146 | $303.3M |
| Q4 2025 | 161 | $561.6M |
| Q3 2025 | 166 | $1.36B |
| Q2 2025 | 114 | $726.4M |
| Q1 2025 | 105 | $541.8M |
| Q4 2024 | 95 | $573.2M |
| Q3 2024 | 78 | $444.9M |
| Q2 2024 | 65 | $327.1M |
| Q1 2024 | 55 | $363.3M |
| Q4 2023 | 63 | $84.2M |
| Q3 2023 | 67 | $75.8M |
| Q2 2023 | 66 | $81.2M |
| Q1 2023 | 62 | $72.9M |
| Q4 2022 | 66 | $95.6M |
| Q3 2022 | 63 | $93.9M |
| Q2 2022 | 63 | $83.0M |
| Q1 2022 | 63 | $185.7M |
| Q4 2021 | 58 | $442.2M |
| Q3 2021 | 60 | $587.4M |
| Q2 2021 | 51 | $1.01B |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding LENZ Therapeutics, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Samsara BioCapital, LLC | 7,431,623 | $228.4M | 30.02% | +7,431,623 | New |
| FMR LLC | 3,761,979 | $110.6M | 0.01% | +3,761,979 | New |
| Ra Capital Management, L.P. | 2,698,369 | $82.9M | 1.33% | +2,698,369 | New |
| Rock Springs Capital Management LP | 2,151,738 | $66.1M | 1.31% | +2,151,738 | New |
| VR Adviser, LLC | 1,612,617 | $49.6M | 6.01% | +1,612,617 | New |
| Citadel Advisors LLC | 1,288,225 | $38.9M | 0.04% | +1,288,225 | New |
| Janus Henderson Group PLC | 1,251,005 | $36.7M | 0.02% | +1,251,005 | New |
| OrbiMed Advisors LLC | 1,106,307 | $34.0M | 0.34% | +1,106,307 | New |
| Logos Global Management LP | 1,070,762 | $32.9M | 2.82% | +1,070,762 | New |
| SB Management Ltd | 993,402 | $30.5M | 0.36% | +993,402 | New |
| Deerfield Management Company, L.P. (Series C) | 906,308 | $27.9M | 0.49% | +906,308 | New |
| Perceptive Advisors LLC | 875,093 | $26.9M | 0.35% | +875,093 | New |
| Avidity Partners Management LP | 735,500 | $22.6M | 0.61% | +735,500 | New |
| Board of Trustees of The Leland Stanford Junior University | 703,701 | $21.6M | 2.02% | +703,701 | New |
| Artal Group S.A. | 700,000 | $21.5M | 0.49% | +700,000 | New |
| Norges Bank | 700,000 | $21.5M | 0.00% | +700,000 | New |
| Federated Hermes, Inc. | 650,000 | $20.0M | 0.04% | +650,000 | New |
| Millennium Management LLC | 589,833 | $18.1M | 0.02% | +589,833 | New |
| UBS Asset Management Americas Inc | 393,787 | $12.1M | 0.01% | +393,787 | New |
| Woodline Partners LP | 309,723 | $9.52M | 0.18% | +309,723 | New |
| Jennison Associates LLC | 300,000 | $9.22M | 0.01% | +300,000 | New |
| Adage Capital Partners GP, L.L.C. | 300,000 | $9.22M | 0.02% | +300,000 | New |
| Goldman Sachs Group Inc | 274,426 | $8.43M | 0.00% | +274,426 | New |
| Morgan Stanley | 263,502 | $8.10M | 0.00% | +263,502 | New |
| Cormorant Asset Management, LP | 203,153 | $5.93M | 0.23% | +203,153 | New |
| Suvretta Capital Management, LLC | 125,000 | $3.84M | 0.06% | +125,000 | New |
| BlackRock Inc. | 103,581 | $3.18M | 0.00% | +103,581 | New |
| Blackstone Group Inc. | 75,000 | $2.31M | 0.01% | +75,000 | New |
| LMR Partners LLP | 70,000 | $2.15M | 0.03% | +70,000 | New |
| Monashee Investment Management LLC | 60,000 | $1.84M | 0.22% | +60,000 | New |
| Pinz Capital Management, LP | 52,543 | $1.61M | 0.49% | +52,543 | New |
| Asymmetry Capital Management, L.P. | 51,039 | $1.57M | 1.08% | +51,039 | New |
| Squarepoint Ops LLC | 40,000 | $1.23M | 0.01% | +40,000 | New |
| Caas Capital Management LP | 40,000 | $1.23M | 0.07% | +40,000 | New |
| Ghisallo Capital Management LLC | 40,000 | $1.23M | 0.05% | +40,000 | New |
| Marshall Wace North America L.P. | 36,646 | $1.13M | 0.00% | +36,646 | New |
| Alyeska Investment Group, L.P. | 30,000 | $922.0K | 0.01% | +30,000 | New |
| Vanguard Group Inc | 30,000 | $921.0K | 0.00% | +30,000 | New |
| Davidson Kempner Capital Management LP | 25,000 | $768.0K | 0.01% | +25,000 | New |
| Sphera Funds Management Ltd. | 24,957 | $767.0K | 0.07% | +24,957 | New |
| Voloridge Investment Management, LLC | 20,000 | $615.0K | 0.00% | +20,000 | New |
| Balyasny Asset Management LLC | 19,232 | $591.0K | 0.00% | +19,232 | New |
| Jane Street Group, LLC | 15,225 | $468.0K | 0.00% | +15,225 | New |
| Qube Research & Technologies Ltd | 14,700 | $452.0K | 0.01% | +14,700 | New |
| Maven Securities LTD | 12,500 | $389.0K | 0.04% | +12,500 | New |
| Tudor Investment Corp Et Al | 12,000 | $369.0K | 0.01% | +12,000 | New |
| Point72 Asset Management, L.P. | 10,000 | $307.0K | 0.00% | +10,000 | New |
| Virtu Financial LLC | 7,709 | $237.0K | 0.02% | +7,709 | New |
| Point72 Hong Kong Ltd | 2,576 | $79.0K | 0.01% | +2,576 | New |
| Bank of America Corp | 200 | $6.00K | 0.00% | +200 | New |
| Royal Bank of Canada | 32 | $1.00K | 0.00% | +32 | New |